The CHKB gene helps cells make a major membrane fat that builds and repairs the outer layer of cells, especially in muscle. This gene plays an important role in helping muscle cells stay stable and work normally. If both copies of the CHKB gene do not work properly, a person can develop a rare inherited muscle condition called megaconial congenital muscular dystrophy, which often causes low muscle tone, muscle weakness, delayed motor milestones, and sometimes learning difficulties. CHKB is mainly known in medical genetics rather than popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do the work. Others mainly help control when certain activities take place, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. More information on this topic is available in the LearnHub.
Overview
CHKBGene function
What if the gene works
The CHKB gene helps cells turn choline into a building block for phosphatidylcholine, a main part of cell membranes. This supports healthy muscle cells and other tissues.
Risk
What if the gene does not work
Pathogenic variants in the CHKB gene can cause a congenital muscle condition with early weakness, delayed milestones, low tone, and learning difficulties. Milder and more severe variants may change when symptoms start and the degree of muscle and brain involvement.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the CHKB gene, no CHKB-specific treatment or drug-selection approach is currently established. The CHKB gene is being studied in muscle disease models and in cell membrane lipid pathways, but this has not yet changed standard care.
Conditions associated with CHKB
Gene function
What if the gene works
In your cells, the CHKB gene supports an early step in making key membrane fats. Its protein helps convert choline into a form cells can use to build phosphatidylcholine, one of the main materials in cell membranes. This is how the CHKB gene helps build cell membranes and support everyday cell upkeep.
The protein made from the CHKB gene adds a phosphate group (a small chemical tag) to choline. This creates phosphocholine, a choline based building block your cells use to make important membrane fats.
Cells use phosphocholine to make phosphatidylcholine, a major fat in cell membranes. This helps provide the flexible outer barrier that surrounds cells and supports normal cell activity.
Cell membranes are constantly being made and refreshed as cells grow, divide, and do daily work. By supporting this pathway, the CHKB gene helps keep a steady supply of membrane material across many tissues.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many do not produce any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHKB gene often reduce or abolish choline kinase beta activity, which can disrupt the cell membrane fats that muscle cells rely on. Some variants mainly make the protein unstable or less active, while more severe variants can truncate it and leave little to no function; this helps explain how CHKB gene variants affect muscle cells. Milder variants may leave some activity, while more disruptive variants are often linked to earlier onset and a broader or more marked form of the condition.
How variants are linked to conditions
Pathogenic variants in the CHKB gene cause megaconial congenital muscular dystrophy, a rare inherited muscle condition. People with this CHKB gene condition often have low muscle tone, delayed motor milestones, muscle weakness, and may also have learning difficulties or heart problems. Finding two disease-causing CHKB variants usually confirms the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widespread across the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHKB, risk is mainly shaped by family history and whether both biological parents carry a disease-causing change in the CHKB gene. There is not enough evidence to say that diet, exercise, or other lifestyle factors change the chance of developing this inherited muscle condition.
Inheritance of CHKB variants
Variants in the CHKB gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit one altered copy from each parent to have a CHKB-related condition. Parents who each carry one CHKB gene variant are typically unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This CHKB gene inheritance pattern affects sons and daughters equally.
What does my CHKB result mean for my family?
For families with a disease-causing CHKB result, close relatives may also carry the same gene change or, less often, be affected if they inherited two changed copies. Brothers and sisters can have a higher chance of sharing the result, and parents are often healthy carriers. Family members may want to discuss whether genetic testing would be useful for them, especially when planning a pregnancy.
Genetic information
Genetic testing
How you find out about variants
CHKB genetic testing looks for changes in the CHKB gene using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA sequence to check for variants and compares the result with known findings. Results may help confirm a diagnosis, clarify carrier status, or support family testing.
When should I consider getting a genetic test?
Consider testing if a child has marked muscle weakness, is late to sit or walk, or has learning difficulties, especially if similar problems run in the family. Finding two disease-causing changes in CHKB can confirm CHKB-related congenital muscular dystrophy and help with family testing.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, factors such as age, lifestyle, environment, and medical history also influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medications. It studies gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CHKB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about medicines, side effects, or how well a treatment is working are best discussed with your doctor or pharmacist. Medical advice is also important before starting, stopping, or changing any regular medicine.
History
The CHKB gene entered medical genetics through research on rare inherited muscle conditions. In 2011, researchers linked variants in the CHKB gene to a form of congenital muscular dystrophy marked by enlarged mitochondria in muscle tissue, a finding that helped define megaconial congenital muscular dystrophy more clearly. From these first observations, research expanded steadily. Later reports showed that the condition can affect both muscle strength and brain development, broadening how clinicians recognized the condition. Over time, descriptions became more precise as genetic testing made it easier to confirm the diagnosis in affected families.